Application Sponsors
ANDA 215077 | ALEMBIC PHARMS LTD | |
Marketing Status
Application Products
001 | SOLUTION;INTRAMUSCULAR | 250MG/5ML (50MG/ML) | 0 | FULVESTRANT | FULVESTRANT |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-12-22 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
ALEMBIC PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 215077
[companyName] => ALEMBIC PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"FULVESTRANT","activeIngredients":"FULVESTRANT","strength":"250MG\/5ML (50MG\/ML)","dosageForm":"SOLUTION;INTRAMUSCULAR","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"FULVESTRANT","submission":"FULVESTRANT","actionType":"250MG\/5ML (50MG\/ML)","submissionClassification":"SOLUTION;INTRAMUSCULAR","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)